Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php on line 2
Immune deviation
LE WE PMID CA
Immune deviation3337Immundeviation

Anisakiasis

Bacteria (Commensal)

Belatacept ttCD80 ttCD86

DINAC

Ecstasy

Imiquimod

Immune deviation

Immunosuppressive agents

Innate immunity

Kidney (Minimal change nephrotic syndrome)

Macrophages

Malaria

Murabutide

Regulatory T cell

Resiquimod

Segmented filamentous bacteria

Sepsis

T cell (Th17)

Transfusion (BASKET)

Ultraviolet radiation (Therapeutic use)

Vasoactive intestinal peptide

2003  
1
Immunomodulation by antimicrobial drugs.
[14567518] Neth J Med 61(7): 233-4 (2003)
1990  
2
Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection.
[2293502] Yale J Biol Med 63(5): 429-33 (1990)
1996  
3
Blood transfusion-induced immunomodulation.
[8712400] Anesth Analg 82(1): 187-204 (1996)
1990  
4
The effect of anesthetic agents on the human immune response.
[2178494] Anesthesiology 72(3): 542-52 (1990)
1971  
5
Anesthesia and the immune response.
[5544626] Anesthesiology 34(3): 271-82 (1971)
2004  
6
Clinical review: immunomodulatory effects of dopamine in general inflammation.
[15566620] Crit Care 8(6): 485-91 (2004)
2003  
7
The antiatherogenic effect of DiNAC: experimental findings supporting immunomodulation as a new treatment for atherosclerosis related diseases.
[12847563] Cardiovasc Drug Rev 21(2): 119-32 (2003)
2008  
8
Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction.
[18026131] Br J Pharmacol 153 Suppl 1(-): S27-34 (2008)
2007  
9
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.
[19707331] Biologics 1(3): 203-13 (2007)
2004  
10
The significance of vasoactive intestinal peptide in immunomodulation.
[15169929] Pharmacol Rev 56(2): 249-90 (2004)
2003  
11
Mechanisms involved in ultraviolet light-induced immunosuppression.
[14721768] Eur J Dermatol 13(6): 515-23 (2003)
2009  
12
B-cell-directed therapy for inflammatory skin diseases.
[19148218] J Invest Dermatol 129(2): 289-301 (2009)
1992  
13
Use of immune modulators in nonspecific therapy of bacterial infections.
[1590674] Antimicrob Agents Chemother 36(1): 1-5 (1992)
2003  
14
Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.
[12493780] J Antimicrob Chemother 51(1): 5-8 (2003)
2001  
15
Imiquimod and resiquimod as novel immunomodulators.
[11733457] J Antimicrob Chemother 48(6): 751-5 (2001)
1966  
16
Symposium on in vitro studies of the immune response. 3. Biochemical agents affecting the inductive phase of the secondary antibody respose initiated in vitro.
[5327954] Bacteriol Rev 30(2): 408-17 (1966)
1966  
17
Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.
[5327460] Bacteriol Rev 30(2): 442-59 (1966)
2000  
18
Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?
[11023961] Clin Microbiol Rev 13(4): 615-50 (2000)
2000  
19
Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function.
[11023954] Clin Microbiol Rev 13(4): 523-33 (2000)
1996  
20
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.
[8894351] Clin Microbiol Rev 9(4): 532-62 (1996)
1996  
21
Immune deviation: a historical perspective.
[8912008] Immunol Cell Biol 74(5): 449-56 (1996)
2002  
22
Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors.
[12522440] Cancer Gene Ther 9(12): 1013-21 (2002)
2002  
23
The cellular basis of post-burn immunosuppression: macrophages and mediators.
[12165794] Int J Mol Med 10(3): 239-43 (2002)
2010  
24
Parasitic helminths: new weapons against immunological disorders.
[20169100] J Biomed Biotechnol 2010(-): 743758 (2010)
2010  
25
Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes.
[20145705] J Biomed Biotechnol 2010(-): 262609 (2010)
2010  
26
Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?
[20718737] Br J Pharmacol 161(1): 17-32 (2010)
2010  
27
New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression.
[20146712] Ann N Y Acad Sci 1183(-): 123-48 (2010)
2008  
28
Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity.
[18400801] Clin Microbiol Rev 21(2): 360-79, table of contents (2008)
2011  
29
Epigenetic regulation of immune cell functions during post-septic immunosuppression.
[21048427] Epigenetics 6(3): 273-83 (2011)
2010  
30
What can we learn from an unnatural immune response?
[20430697] Trends Parasitol 26(7): 319-21 (2010)
2010  
31
Segmented filamentous bacteria take the stage.
[20147894] Mucosal Immunol 3(3): 209-12 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immune deviation.php on line 92